- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06204848
Imaging of Vitreous Opacities in a Canadian Population
April 1, 2024 updated by: PulseMedica
Acquisition of Imaging Data of Vitreous Opacities in Human Eyes Using a Non-Invasive Imaging Device
The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in.
Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
125
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Study Coordinator
- Phone Number: 242 780-448-1801
- Email: research@alberta-retina.com
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada
- Alberta Retina Consultants
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 18 years or older
- Symptomatic vitreous opacities (floaters) in vision
- Clear ocular media, to allow a clear view of the vitreous for the SVO-ID
Exclusion Criteria:
- Younger than 18 years of age
- Presence of vitreous hemorrhage
- Cataract Grade 3 and above
- Opacification of lens or cornea, lens, or vitreous
- Diagnosis of narrow angle glaucoma
- Refractive error is outside the range of -6D to+3D
- Astigmatism is outside the range of +/-2D of cylinder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Imaging using the SVO-ID
Patients will have their eyes imaged with the SVO-ID as part of a study visit.
|
Combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for imaging of the eye
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful capture of SLO and OCT imaging data of SVOs for algorithm development
Time Frame: Through study completion, an average of 6-8 months
|
Successful collection of SLO and OCT imaging data
|
Through study completion, an average of 6-8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Collection of patient-reported symptoms
Time Frame: Through study completion, an average of 6-8 months
|
Patient feedback regarding symptoms related to SVOs being imaged
|
Through study completion, an average of 6-8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
November 1, 2024
Study Registration Dates
First Submitted
January 3, 2024
First Submitted That Met QC Criteria
January 3, 2024
First Posted (Actual)
January 12, 2024
Study Record Updates
Last Update Posted (Actual)
April 3, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SVO-IDFIH002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Floaters
-
PulseMedicaRecruiting
-
Jeanette DuNot yet recruiting
-
University of British ColumbiaCompleted
-
Ophthalmic Consultants of BostonCompletedPosterior Vitreous Detachment | Weiss Ring | Floaters
Clinical Trials on SVO-ID
-
PulseMedicaRecruiting
-
PATHSID TechnologiesCompletedInjections, IntradermalUnited States
-
Idorsia Pharmaceuticals Ltd.CompletedRenal ImpairmentGermany
-
Aga Khan UniversityWorld Health OrganizationCompleted
-
Seoul National University HospitalUnknownAbnormal Bowel Movement Such as Constipation, Diarrhea, Abdominal PainKorea, Republic of
-
PATHCompletedInjections, IntradermalUnited States
-
Queen's University, BelfastUniversity of Sheffield; University of Glasgow; University of South Wales; Baily...Recruiting
-
Medical Research Council Unit, The GambiaCenters for Disease Control and Prevention; World Health OrganizationCompleted
-
National Cancer Center, KoreaBoston Scientific CorporationNot yet recruitingRadiotherapy | Biliary Tract Carcinoma | Radio-frequency Ablation
-
Medical University of South CarolinaCompletedMedication AdherenceUnited States